We aimed to examine whether a difference exists in the clinical and microbiological features of Bartholin's gland abscess during pregnancy and the puerperium as compared with nonpregnant patients. In addition, we aim to evaluate whether a Bartholin's gland abscess during pregnancy is associated with adverse pregnancy outcomes. STUDY DESIGN: A retrospective cohort study was conducted, including all women with Bartholin' gland abscess who were treated surgically between the years 2009-2016 in the Soroka University Medical Center. Various demographic, clinical and microbiological characteristics were retrieved and a comparison was made between patients with a Bartholin's gland abscess during pregnancy and the puerperium (study group) as compared with non-pregnant patients (controls). In addition, obstetrical characteristics of patients in the study group were retrieved. RESULTS: of 363 women who were treated surgically 38 (2.2%) were in the study group. Women in the study group were significantly younger (26.8 vs. 32.8 p<0.001). No differences were found between the groups with regard to the clinical presentation (affected side, fever, leukocytosis and need for antimicrobial treatment) or the selected mode of drainage. In addition, no difference was found in the percentage of positive culture results, nor in the distribution of the pathogens between the groups, in both groups the most common pathogen was Escherichia coli. Yet, among the study group recurrence of the abscess was more common (13.5% vs. 2.15% p-0.067) as evident by significantly higher recurrent referrals to the emergency department and recurrent hospitalizations (28.9% vs. 14.8%, p< 0.05, and 26.3% vs. 8.0% p<0.001, respectively). Of note, fever after the procedures, pain, discharge and bleeding did not differ significantly between groups. The mean time interval between treatment and delivery among pregnant patients was 10.5AE12.1 weeks. No cases of premature rupture of membranes or chorioamnionitis were noted following treatment. CONCLUSION: In our cohort, no differences were found between the study groups in the clinical presentation and microbiological features. A significantly higher recurrence rate was noted in the study group. Among pregnant patients no adverse perinatal outcomes were noted. OBJECTIVE: Stillbirth complicates 1 in 160 deliveries in the United States. ACOG suggests initiation of antenatal fetal surveillance (ANFS) in most "at risk" women beginning at 32 weeks' gestation. We sought to quantify the distribution of stillbirths by gestational age (GA) in a contemporary cohort and to determine identifiable risk factors associated with early (<32 weeks) stillbirth. STUDY DESIGN: Population-based retrospective cohort study of all stillbirths in the US during the year 2014. Distribution of stillbirths were stratified by GA, 20-44 wks, in women diagnosed with stillbirth in the antepartum period (non-laboring). Maternal, obstetric, and fetal characteristics were compared between those diagnosed with early (< 32 wks) vs late (!32 wks) occurrence of stillbirth. Multivariate logistic regression estimated the relative influence of various maternal, obstetric, and fetal factors on the outcome of early stillbirth. RESULTS: There were 15,998 non-laboring women diagnosed with stillbirth during 2014 in the U.S. between GA 20-44 weeks. Of those, 60.1% (n¼9,618) occurred before ANFS is typically initiated (< 32 wks) and 39.9% (n¼6,380) were diagnosed ! 32 wks. Median GA at diagnosis was 23 (IQR 21,27) vs 37 (IQR (34,39) wks between GA cohort groups. Women with early stillbirth were more likely to be of Non-Hispanic Black race (29.0 vs 23.9%, p<0.001), to be primiparous (53.8 vs 50.6%, p¼0.001), have chronic HTN (6.0 vs 4.3%, p<0.001) and lagging fetal growth as evidenced by small for gestational age (SGA<10 th %) birthweight (44.8 vs 42.1%, p<0.001). After adjusting for coexistent risk in multivariate analysis, SGA
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